IMMUNOCHEM THERAPEUTICS LLC
AUBURNDALE, United States · Founded 2018
- Headquarters
- AUBURNDALE, Massachusetts
- Employees
- 1–10
- Founded
- 2018
- Business Model
- B2B
About
ImmunoChem Therapeutics is a clinical-stage Northwestern University spinout developing brain-penetrant small molecule drugs that suppress neuroinflammation, a key driver of cognitive decline in Alzheimer's disease, brain injury, and stroke. The company has advanced two CNS-penetrant assets into Phase 1 clinical trials, backed by over $4 million in NIH SBIR and STTR grants.
Summary
IMMUNOCHEM THERAPEUTICS LLC is a Biotech company based in AUBURNDALE, United States, founded in 2018.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/immunochem-therapeutics-llc"><img src="https://indexed.vc/api/badge/company/immunochem-therapeutics-llc" alt="IMMUNOCHEM THERAPEUTICS LLC on Indexed.vc" width="260" height="76" /></a>